Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,220 | 2,210 | 1,620 | 2,280 | 1,840 |
| TOTAL | $1,220 | $2,210 | $1,620 | $2,280 | $1,840 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 60,950 | 61,980 | 63,230 | 63,950 | 65,490 |
| TOTAL | $60,950 | $61,980 | $63,230 | $63,950 | $65,490 |
| Total Assets | $62,170 | $64,190 | $64,850 | $66,230 | $67,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 22,670 | 12,080 | 22,090 | 6,080 | 4,860 |
| Accounts payable and accrued liabilities | 20,320 | 19,860 | 18,830 | 19,380 | 15,600 |
| Other current liabilities | 6,710 | 8,910 | 9,690 | 9,780 | 5,230 |
| TOTAL | $51,140 | $46,070 | $50,610 | $39,440 | $26,350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,700 | 7,720 | 7,900 | 7,710 | 22,330 |
| TOTAL | $26,750 | $27,860 | $29,120 | $30,200 | $22,330 |
| Total Liabilities | $77,890 | $73,930 | $79,730 | $69,640 | $48,680 |
| Shareholders' Equity | |||||
| Common Shares | 80 | 80 | 70 | 70 | 70 |
| Other shareholders' equity | 1,460 | 1,860 | 3,010 | 3,250 | 2,460 |
| TOTAL | $447,800 | $447,140 | $445,740 | $443,470 | $442,110 |
| Total Liabilities And Equity | $525,690 | $521,070 | $525,470 | $513,110 | $490,790 |